Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SMMT
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Summit Therapeutics Inc (SMMT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Summit Therapeutics (SMMT) trades at $17.605, up 2.83% with strong bullish technical signals and positive analyst sentiment. The stock shows momentum with moving averages indicating upward trend potential. Recent clinical trial successes for ivonescimab in lung and biliary tract cancers have driven investor optimism, though the company continues to report significant losses with negative ROE of -192.5% and substantial cash burn from operations.
The investment case hinges on FDA approval of ivonescimab by November 2026, with analyst consensus target of $25.23 suggesting 43% upside. However, high cash burn, negative profitability metrics, and binary regulatory outcome create substantial risk-reward dynamics for speculative biotech investors.
Read full analysis

Key Stats

  • Market Cap
    $14.04B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.38
  • 52W Low
    $12.43
  • Typical Hold Time
    -
  • Enterprise Value
    $13.37B
  • Div Yield
    -
  • Trading Activity
    -
$17.61
52W Low: $12.43
20 Aug 2026
52W High: $26.38
21 Apr 2026

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.43 and a high of $26.38, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

RBC raises price targets for B&M and Currys as fashion retailers cut homewares prices

RBC Capital Markets has increased its price targets for B&M European Value Retail and Currys, citing more competitive homewares pricing from international fashion retailers like Zara and H&M. B&M's price target rose to 275p from 240p due to improved ...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
RBC raises price targets for B&M and Currys as fashion retailers cut homewares prices

Six Flags launches Flex Pay, letting guests buy Season Passes now and pay in installments.

Six Flags Entertainment Corporation introduced Flex Pay by Upgrade, a new payment option allowing guests to purchase Season Passes and other qualifying products online for $49 or more and pay over time in fixed monthly installments. This option lets ...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
Six Flags launches Flex Pay, letting guests buy Season Passes now and pay in installments.

Tesla struggles financially despite pitching itself as an AI company, stock down 21% YTD.

Tesla is promoting itself as an AI company with projects like Robotaxi and Optimus robots, but its financials tell a different story. The company reported a 56.88% drop in operating income and negative free cash flow due to soaring capital expenditur...

Market News
4 hours ago
24/7 Wall Street
Bearish
news icon
Tesla struggles financially despite pitching itself as an AI company, stock down 21% YTD.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $14.04B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.38
  • 52W Low
    $12.43
  • Typical Hold Time
    -
  • Enterprise Value
    $13.37B
  • Div Yield
    -
  • Trading Activity
    -
$17.61
52W Low: $12.43
20 Aug 2026
52W High: $26.38
21 Apr 2026

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.43 and a high of $26.38, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!